Join connect
CONNECT
Cognitive decline in Nephro-Neurology: European Cooperative Target
CONNECT Action aims to coordinate research on cognitive impairment in chronic kidney disease (CKD). This requires exchanging clinical information between nephrologists and neurologists, and between neuroscientists and kidney physiologists, guided by big data analysts.
This collaborative network will define new experimental paradigms, their translational value and, in turn, focus on new interventions in the field of cognitive impairment.
Main Information
Objectives
OBJECTIVES
Working Groups
Working Groups
RESULTS
Latest News
Latest Tweets
Cognitive decline related to chronic kidney disease as an exclusion factor from kidney transplantation: results from an international survey
Authors: Michele Farisco, Inga A Blumblyte, Casper Franssen, Dorothea Nitsch, Irene Zecchino, Giovambattista Capasso, Gaye Hafez, COST CONNECT Action Collaborators View Publication Background and hypothesisThere seems to be a lack of consensus on the necessity and the
61st ERA Congress in Stockholm
We are attending the 61st ERA Congress in Stockholm on May 23-26, 2024. “CONNECT trajectories”. The program is available here.
Fifth Call for Short-Term Scientific Mission
Fifth Call for Short-Term Scientific Mission (STSM) applications within the COST Action “Cognitive decline in Nephro-Neurology: European Cooperative Target (CONNECT)” Deadline for submission: April 13th, 2024 Expected date of notification of
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
Authors: Michelangela Barbieri, Paolo Chiodini, Piergiacomo Di Gennaro, Gaye Hafez, Sophie Liabeuf, Jolanta Malyszko, Laila-Yasmin Mani, Francesco Mattace Raso, Marion Pepin, Norberto Perico, Mariadelina Simeoni, Carmine Zoccali, Giovanni Tortorella, Annalisa Capuano, Giuseppe Remuzzi, Giovambattista Capasso, Giuseppe Paolisso, on behalf of CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators Patients with chronic kidney disease (CKD) often experience mild cognitive impairment and other